Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) FCF Margin (2021 - 2025)

Historic FCF Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 8.67%.

  • MDxHealth's FCF Margin rose 165500.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 153400.0%. This contributed to the annual value of 48.81% for FY2024, which is 59600.0% down from last year.
  • As of Q3 2025, MDxHealth's FCF Margin stood at 8.67%, which was up 165500.0% from 0.0% recorded in Q2 2025.
  • MDxHealth's FCF Margin's 5-year high stood at 59.3% during Q1 2023, with a 5-year trough of 414.12% in Q2 2022.
  • In the last 5 years, MDxHealth's FCF Margin had a median value of 32.51% in 2023 and averaged 64.43%.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 3082100bps in 2023, then tumbled by -260000bps in 2024.
  • Quarter analysis of 5 years shows MDxHealth's FCF Margin stood at 116.48% in 2021, then soared by 40bps to 69.41% in 2022, then surged by 53bps to 32.51% in 2023, then rose by 16bps to 27.45% in 2024, then skyrocketed by 68bps to 8.67% in 2025.
  • Its FCF Margin stands at 8.67% for Q3 2025, versus 0.0% for Q2 2025 and 20.85% for Q1 2025.